At a glance
Goldman Sachs Alternatives appears in 9 funding rounds tracked by ValueAddVC since 2026, leading 5. Its most frequent sector in these rounds is Fintech & Crypto, and its most recent tracked deal was Cyera's $400M Series G extension round (Sep 22, 2026). It co-invests most often with GIC, Lightspeed Venture Partners and Tiger Global Management.
Strategy
Geographies
New York, New York, USA
Recent changes
- Sep 22, 2026Sep 22, 2026Invested in Cyera (Series G extension, $400M) PYMNTS
- Sep 14, 2026Sep 14, 2026Invested in Temporal (Series E, $550M) Temporal
- Aug 28, 2026Aug 28, 2026Invested in Owner (Growth, $240M) Crunchbase News
- Aug 27, 2026Aug 27, 2026Invested in Socure (Growth, $156M) Crunchbase News
- Aug 17, 2026Aug 17, 2026Invested in Higgsfield (Series B, $400M) TechCrunch
Earlier changes (3)
- Aug 11, 2026Aug 11, 2026Invested in Vaderis Therapeutics (Series B, $152.5M) PR Newswire
- Jun 24, 2026Jun 24, 2026Invested in Taktile (Series C, $110M) PYMNTS
- Jun 4, 2026Jun 4, 2026Invested in Ramp (Series F, $750M) PR Newswire
Portfolio
10 totalRecent Investment Activity
9Track record: led 5 and participated in 4 of 9 tracked venture rounds · 9 in the last 12 months · led 1 Series G extension, 1 Growth, 1 Series B, 1 Series D
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Cyera | Series G extension | Led | $400M | $12B | PYMNTS | |
| Sep 14, 2026 | Temporal | Series E | Participated | $550M | $12.55B | Temporal | |
| Aug 28, 2026 | Owner | Growth | Led | $240M | $2.3 billion | Pulse story | |
| Aug 27, 2026 | Socure | Growth | Participated | $156M | $5.2B | Crunchbase News | |
| Aug 17, 2026 | Higgsfield | Series B | Participated | $400M | $5.4B | TechCrunch | |
| Aug 11, 2026 | Vaderis Therapeutics | Series B | Led | $152.5M | — | Goldman Sachs AlternativesLeadTCGXLead | Pulse story |
| Jul 15, 2026 | Spectro Cloud | Series D | Led | $100M+ | — | Goldman Sachs AlternativesLeadunverifiedAMD VenturesunverifiedLG Technology VenturesunverifiedEricssonMaximus | Spectro Cloud |
| Jun 24, 2026 | Taktile | Series C | Led | $110M | — | PYMNTS | |
| Jun 4, 2026 | Ramp | Series F | Participated | $750M | $44B | PR Newswire |
Sector / Stage Activity
By sector (portfolio)
Fintech
3 · 30%
Biotech
2 · 20%
Cybersecurity
1 · 10%
AI infra
1 · 10%
Enterprise SaaS
1 · 10%
By stage (tracked rounds)
Growth
2 · 22%
Series B
2 · 22%
Series G extension
1 · 11%
Series E
1 · 11%
Series D
1 · 11%
Series C
1 · 11%
Series F
1 · 11%
Co-Investors
12Accel · 2 sharedCoatue Management · 2 sharedSpark Capital · 2 sharedConversion Capital · 2 sharedGIC · 2 sharedLightspeed Venture Partners · 2 sharedT. Rowe Price · 2 sharedTiger Global Management · 2 sharedDeep Track Capital · 1 sharedEcoR1 Capital · 1 sharedFrazier Life Sciences · 1 sharedIllumina Ventures · 1 shared
Value Add Research
- AI & Technology · Oct 1, 2026Cyera Valuation 2026: $12B After $400M Series G Extension
- Market & Trends · Oct 1, 2026How Does Rippling Make Money: PEPM Pricing, PEO Margins
- AI & Technology · Sep 24, 2026Temporal Valuation 2026: $12.55B Series E and $250M ARR Explained
- VC & Investing · Sep 7, 2026Menlo Ventures 2026: $3B Fund, $14B Anthropic Stake, New Deals
- Market & Trends · Sep 2, 2026Socure Valuation 2026: $5.2B, $364M ARR, and the Fravity Deal
- AI & Technology · Aug 18, 2026$400M at $5.4B — Higgsfield AI Video
- VC & Investing · Jul 28, 2026$110M Taktile Series C — Goldman Sachs Backs
- Market & Trends · Jul 23, 2026$1.8B at $18B — Helsing Defense Tech (2026)
Latest Pulse
- Sep 22, 2026Cyera Adds $400M From Goldman At $12B ValuationCyera raised a $400 million extension to its Series G from Goldman Sachs Alternatives, holding its $12 billion valuation flat from June as the data-security company builds out AI agent monitoring.→
- Sep 21, 2026Temporal Raises $550M As Agentic AI Needs Durable CodeTemporal Technologies raised a $550 million Series E (announced September 14) at a $12.55 billion valuation led by Lightspeed, as demand for durable execution infrastructure grows alongside longer-running agentic AI workloads.→
- Sep 14, 2026Nine US Rounds, $8.7B, Ten Days: September's Real PaceValue Add Pulse totaled the nine largest US venture rounds of September 5-11 and found $8.7 billion committed, with three deals at $1 billion or more.→
- Sep 9, 2026Harvey Raises $550M At $15.5B ValuationLegal AI startup Harvey raised $550 million at a $15.5 billion valuation, nearly doubling in nine months across two rounds while building its own open-weight model instead of depending solely on OpenAI or Anthropic.→
- Aug 28, 2026Owner Raises $240M at $2.3B to Run Local BusinessesOwner, the AI platform that runs websites, ordering, marketing and phone support for restaurants, raised $240 million led by Growth Equity at Goldman Sachs Alternatives at a $2.3 billion valuation.→
- Aug 28, 2026Socure Raises $156M at $5.2B and Buys FravityIdentity-verification company Socure raised $156 million led by Summit Partners at a $5.2 billion valuation and acquired agentic AI startup Fravity, disclosing $364 million of annual recurring revenue growing 63% year over year.→
- Aug 27, 2026Socure Raises $156M at $5.2B, Buys FravityIdentity-verification firm Socure raised $156 million at a $5.2 billion valuation and simultaneously acquired agentic fraud-investigation startup Fravity, folding its technology into a new RiskOS_Agents product line.→
- Aug 17, 2026Higgsfield Quadruples Valuation to $5.4B in 8 MonthsAI video and image startup Higgsfield raised a $400 million Series B at a $5.4 billion valuation, four times its mark from eight months ago, on $700 million in annualized revenue.→
- Aug 13, 2026Databricks Closes $5B Round at $190B ValuationDatabricks closed a $5 billion round at a $190 billion valuation led by Coatue, after the company said it crossed a $7 billion annualized revenue run-rate with more than 80% year-over-year growth.→
- Aug 11, 2026Vaderis Raises $152M Series B for Rare Disease TrialVaderis Therapeutics closed an oversubscribed $152.5 million Series B co-led by Goldman Sachs Alternatives and TCGX to fund a global Phase 3 trial of its drug for a rare blood vessel disorder.→
- Jul 29, 2026Goldman-Backed Attovia Seeks $212.5M in Biotech IPOAttovia Therapeutics is seeking up to $212.5 million in a US IPO, offering 12.5 million shares at $15-$17 each, backed by Goldman Sachs Alternatives, Deep Track Capital, Frazier Life Sciences, and venBio.→
- Jul 14, 2026Europe's Defense-Tech Rounds Are Catching Up to the USHelsing's $1.8 billion round at an $18 billion valuation puts a concrete number on how fast European defense-tech financing is closing the gap with a US market that produced four separate billion-dollar-plus rounds this year alone.→
- Jul 14, 2026The AI Trade Just Split in Two: Buyers vs. SellersNvidia has shed roughly $1 trillion in value since May even as Meta's data center costs balloon past $50 billion and Helsing raises Europe's biggest-ever defense round -- capex is up, but the margin is shifting away from the chip seller.→
- Jul 13, 2026Helsing Raises $1.8B, Europe's Biggest Defense RoundMunich-based Helsing closed a $1.8 billion Series E at an $18 billion valuation, Europe's biggest-ever defense-tech round, with Goldman Sachs Alternatives, CPPIB and JPMorgan joining as new investors amid oversubscribed demand.→
- Jun 24, 2026Taktile Raises $110M Series C Led by Goldman Sachs for AI Decisioning in FinanceTaktile raised a $110 million Series C led by Goldman Sachs Alternatives to scale its AI decisioning platform, which lets banks and insurers automate underwriting, claims, fraud detection and anti-money-laundering workflows with human oversight. The round is a vote of confidence that regulated financial institutions will pay for AI that makes high-stakes decisions auditable rather than just faster.→
- Jun 4, 2026Ramp Raises $750M Series F at a $44B Valuation as Fintechs With an AI Story Command PremiumsSpend-management company Ramp raised $750 million in a Series F at a $44 billion valuation, led by Iconiq, GIC and Ontario Teachers' Pension Plan -- nearly tripling its valuation in a year. With annualized revenue past $1 billion and 70,000+ customers, Ramp has become the marquee example of investors paying up for fintechs that have credibly bolted on AI.→
Goldman Sachs Alternatives FAQ
What companies has Goldman Sachs Alternatives invested in?
Goldman Sachs Alternatives' portfolio includes Cyera, Temporal, Owner, Socure, Higgsfield, Vaderis Therapeutics, and 4 more tracked companies.
Who does Goldman Sachs Alternatives co-invest with most?
In the rounds Value Add tracks, Goldman Sachs Alternatives most often invests alongside Accel (2 shared deals), Coatue Management (2 shared deals), Spark Capital (2 shared deals), Conversion Capital (2 shared deals), GIC (2 shared deals).
Sources & methodologyshow
Where these figures come from
- PR Newswireprimary source1 fact
- PR Newswireprimary source1 fact
- Temporalprimary source1 fact
- TechCrunchmajor outlet1 fact
- Crunchbase Newsresearch database1 fact
- Crunchbase Newsresearch database1 fact
- PYMNTSValue Add VC data1 fact
- PYMNTSValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.